Increasing the homogeneity, stability and activity of human serum albumin and interferon-α2b fusion protein by linker engineering

Protein Expression and Purification

Volumn 61, Issue 1, 2008, Pages 73-77

  Zhao, Hong Liang ^a   Yao, Xue Qin ^a   Xue, Chong ^a   Wang, Yang ^a   Xiong, Xiang Hua ^a   Liu, Zhi Min ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

HSA fusion protein; Linker engineering; Pichia pastoris

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; HYBRID PROTEIN; SERUM ALBUMIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; ELECTROPORATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR CLONING; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ENGINEERING;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CLONING, MOLECULAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPORATION; HUMANS; INTERFERON ALFA-2B; PLASMIDS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; SERUM ALBUMIN;

PICHIA PASTORIS;

EID: 47749104481     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.04.013     Document Type: Article

References (16)

1. Esposito D., and Chatterjee D.K. Enhancement of soluble protein expression through the use of fusion tags. Curr. Opin. Biotechnol. 17 (2006) 353-358
2. Fujikawa K., Kawakami A., and Eguchi K. Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein. Nippon Rinsho 65 (2007) 1211-1217
3. Osborn B.L., Olsen H.S., Nardelli B., Murray J.H., Zhou J.X., Garcia A., Moody G., Zaritskaya L.S., and Sung C. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys. J. Pharmacol. Exp. Ther. 303 (2002) 540-548
4. Bain V.G., Kaita K.D., Yoshida E.M., Swain M.G., Heathcote E.J., Neumann A.U., Fiscella M., Yu R., Osborn B.L., Cronin P.W., Freimuth W.W., McHutchison J.G., and Subramanian G.M. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients. J. Hepatol. 44 (2006) 671-678
5. Subramanian G.M., Fiscella M., Lamousé-Smith A., Zeuzem S., and McHutchison J.G. Alb interferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C. Nat. Biotechnol. 25 (2007) 1411-1419
6. Zhao H.L., Xue C., Wang Y., Li X.Y., Xiong X.H., Yao X.Q., and Liu Z.M. Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha2b fusion protein by altering its orientation. J. Biotechnol. 131 (2007) 245-252
7. Wriggers W., Chakravarty S., and Jennings P.A. Control of protein functional dynamics by peptide linkers. Biopolymers 80 (2005) 736-746
8. George R.A., and Heringa J. An analysis of protein domain linkers: their classification and role in protein folding. Protein Eng. 15 (2002) 871-879
9. Crasto C.J., and Feng J.A. LINKER: a program to generate linker sequences for fusion proteins. Protein Eng. 13 (2000) 309-312
10. Arai R., Ueda H., Kitayama A., Kamiya N., and Nagamune T. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 14 (2001) 529-532
11. McCormick A.L., Thomas M.S., and Heath A.W. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120. J. Infect. Dis. 184 (2001) 1423-1430
12. Bai Y., and Shen W.C. Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization. Pharm. Res. 23 (2006) 2116-2121
13. Gustavsson M., Lehtiö J., Denman S., Teeri T.T., Hult K., and Martinelle M. Stable linker peptides for a cellulose-binding domain-lipase fusion protein expressed in Pichia pastoris. Protein Eng. 14 (2001) 711-715
14. Kavoosi M., Creagh A.L., Kilbum D.G., and Heynes C.A. Strategy for selecting and characterizing linker peptides for CBM9-tagged fusion proteins expressed in Escherichia coli. Biotechnol. Bioeng. 98 (2007) 599-610
15. Ruiz L., Reyes N., Duany L., Franco A., Aroche K., and Hardy Rando E. Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin. Int. J. Pharm. 264 (2003) 57-72
16. Kim G.B., Wang Z., Liu Y.Y., Stavrou S., Mathias A., Goodwin K.J., Thomas J.M., and Neville D.M. A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin. Protein Eng. Des. Sel. 20 (2007) 425-432